SaNOtize Research and Development Corporation, a biotech company based in Vancouver, is one of the agencies at the forefront of the efforts to prevent and treat COVID-19. This past May, SaNOtize announced that enrolment of its first participant in a multi-center Phase II trial of its patented Nitric Oxide Releasing Solution (NORS) for the prevention and early treatment of COVID-19.
